Results

Total Results: 576 records

Showing results for "Practice Guideline for the Treatment of Patients with Eating Disorders (NGC)".

  1. cds.ahrq.gov/cdsconnect/artifact/statin-therapy-prevention-and-treatment-cardiovascular-disease-cvd-electronic
    July 10, 2017 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  2. cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Summary_July_2021.pdf
    January 01, 2021 - for asthma diagnosis, management, and treatment. … recommendations for preferred therapies only in certain circumstances. … is triggered; if, on the other hand, a patient is on the preferred therapy for a step and the provider … orders an escalation to the next step with a non- preferred therapy, then the CDS will trigger a notification … that neither specializes in asthma treatment nor has many patients with asthma.
  3. cds.ahrq.gov/sites/default/files/cds/artifact/1166/Logic_Flow_Alcohol_Screening_Using_WHO_AUDIT_%20CDS_0.pdf
    July 14, 2020 - CDS Logic Flow: Alcohol Screening Using the (WHO) AUDIT 7/14/2020 Clinical Decision Support (CDS) … Logic Flow: Alcohol Screening Using the World Health Organization (WHO) Alcohol Use Disorders Identification … Test (AUDIT) Additional details regarding the CDS logic and specifications are available in the implementation … Clinical Decision Support (CDS) Logic Flow: Alcohol Screening Using the World Health Organization (WHO
  4. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
    January 01, 2020 - most important to patients and those who care for them. … The team also continued working with a patient/caregiver activist, Danny van Leeuwen of HealthHats, … CVD Prevention in Adults With Cardiovascular Risk Factors No Yes Yes No Statin Therapy for the … https://cds.ahrq.gov/cdsconnect/artifact/statin-therapy-prevention-and-treatment-cardiovascular-disease-cvd-ecqm … https://cds.ahrq.gov/cdsconnect/artifact/statin-therapy-prevention-and-treatment-cardiovascular-disease-cvd-ecqm
  5. cds.ahrq.gov/sites/default/files/workgroups/1116/AHRQ%20-%202020%20January%20CDS%20Connect%20Workgroup%20slides-508.pdf
    November 07, 2018 - learned for use of the CDS Connect Authoring Tool in Academia • Discuss topics of interest to members … CDS Hooks v1.0 • Artifacts ► Statin Therapy for the Prevention and Treatment of Cardiovascular Disease … //github.com/AHRQ-CDS/AHRQ-CDS-Connect-CQL-SERVICES https://cds.ahrq.gov/cdsconnect/artifact/statin-therapy-prevention-and-treatment-cardiovascular-disease-cvd-ecqm … You will also need to send me screenshots of your test with the five patients. … 2) Test patients: • Patient-A.json: Patient A: Age: 20; Pneumonia: Yes; Already prescribed Bicillin
  6. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - be adjusted for patients with familial hypercholesterolemia, or patients who are not White or African-American … Define “treatment for hypertension” as the existence of an active antihypertensive medication in thewith statin therapy or aspirin therapy prior to changing or initiating therapy. … from Cardiovascular Preventive Therapies in Medicare Patients: Development of the Longitudinal ASCVD … with statin therapy or aspirin therapy prior to changing or initiating therapy by adding to the CQL
  7. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - presence of diabetes, and treatment for high blood pressure. … , hypertension treatment, aspirin therapy, and/or smoking cessation were to be initiated. … be adjusted for patients with familial hypercholesterolemia, or patients who are not white or African-American … benefits and harms of specific therapies so the patient can make an informed decision "after" The … " One or more of the following: smoking cessation, hypertension treatment, statin therapy, or aspirin
  8. cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
    April 01, 2021 - of artifacts are primarily for use by clinicians and patients performing assessment and treatment planning … be adjusted for patients with familial hypercholesterolemia, or for patients who are not White or African … , or combinations of therapies, and weigh this in the context of other considerations, including patienttherapies so the patient can make an informed decision. … “one or more therapies” One or more of the following: smoking cessation, hypertension treatment, statin
  9. cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_5_Actions.html
    January 01, 1970 - scores, such as the CURB-65 criteria to identify patients with CAP who may be candidates for out- patienttreatment. … suggestive clinical features is required for the diagnosis of pneumonia Rec_3: Imp_4: Dir_4 a demonstrable … infiltrate by chest radiograph or other imaging technique is required for the diagnosis of pneumonia … Rec_3: Imp_4: Dir_6 Patients with CAP should be investigated for specific pathogens Rec_2: Cond_2:
  10. cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_Work_Group_February_2022_slides.pdf
    January 01, 2022 - tools for health and wellbeing in the hands of the person and their healthcare team … to Bring Data to the Point of Need 17 ACTIVATE Platform v.1 for Data at the Point of Need Panel … Feasibility pilot • 12 patients enrolled Apr – Jul 2021 • Hemoglobin A1c for patients with diabetes … at 3 months = 2.4-point reduction • Blood pressure for patients with hypertension at 3 months = … Point of Need ACTIVATE Platform v.1 for Data at the Point of Need (cont.)
  11. cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - For example: · Out-of-range LDL result – substitute with the closest end range value and display the … Intermediary values are less useful. · Parameter ranges should be consistent with what the patient could … For example: · A patient with a past rhabdomyolysis diagnosis due to a previous fall shouldn’t be excluded … from a statin therapy recommendation. · Many people with liver disease other than cirrhosis, e.g. fatty … discretion of the provider, even if the patient is already on statins, which is not always easy to determine
  12. cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
    January 01, 2018 - The first section calculates the population of patients who meet the inclusion criteria for the CDS … ASCVD (prior to initiation of preventive therapies). … Using this API, clients post FHIR DSTU223 patient data, runtime parameter values, and desired result … to the client. … office that oversees a clinical practice guideline) participate in the translation of the evidence
  13. cds.ahrq.gov/sites/default/files/workgroups/1216/CDS_Connect_Work_Group_October_2020_Summary.pdf
    January 01, 2020 - of interest to members relating to opportunities for CDS Connect ACTION ITEMS • Email the MITRE team … prioritization for the upcoming option year of CDS Connect. … In terms of trust, familiarizing laypersons with the existence of those artifacts with a strong patient-facing … 2) providing a means of artifact validation for developers while authoring, perhaps in the form ofof hydroxychloroquine, now used in some COVID treatments, was triggering results in older implementation
  14. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - The artifact is intended for asymptomatic patients. … Specifies the logic necessary for querying patient records and returning the recommended PEP treatment … contain ingredient/substance codes for any of the potentially recommended PEP treatments. … drug therapy regardless of pregnancy trimester OR “Options for treatment, depending on allergies, … Add explanation Options for treatment presented even if the patient is allergic The most
  15. cds.ahrq.gov/cdsconnect/artifact/healthy-diet-and-physical-activity-cvd-prevention-adults-cardiovascular-risk
    June 01, 2019 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  16. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
    October 28, 2021 - Rule 1 Test Cases Test Cases Rule to Test Patient Name Specific Situation Age Current Asthma Med 1 … any population End of worksheet. 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapythe ciclesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step … the budesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step 4 … any population End of worksheet.
  17. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27776/Test-Cases.xlsx
    October 28, 2021 - Rule 1 Test Cases Test Cases Rule to Test Patient Name Specific Situation Age Current Asthma Med 1 … any population End of worksheet. 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapythe ciclesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step … the budesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step 4 … any population End of worksheet.
  18. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
    October 28, 2021 - Rule 1 Test Cases Test Cases Rule to Test Patient Name Specific Situation Age Current Asthma Med 1 … any population End of worksheet. 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapythe ciclesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step … the budesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step 4 … any population End of worksheet.
  19. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
    October 28, 2021 - Rule 1 Test Cases Test Cases Rule to Test Patient Name Specific Situation Age Current Asthma Med 1 … any population End of worksheet. 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapythe ciclesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step … the budesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step 4 … any population End of worksheet.
  20. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
    October 28, 2021 - Rule 1 Test Cases Test Cases Rule to Test Patient Name Specific Situation Age Current Asthma Med 1 … any population End of worksheet. 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapythe ciclesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step … the budesonide, which would not be preferred therapy so give the 6a recommendation 6a: adult Step 4 … any population End of worksheet.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: